We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

BellBrook Labs Launches Methyltransferase Assay to Accelerate Epigenetic Drug Discovery

Product News   Aug 14, 2017

 
BellBrook Labs Launches Methyltransferase Assay to Accelerate Epigenetic Drug Discovery

Methyltransferases have become a major focus of drug discovery for cancer and other diseases driven by epigenetic factors. BellBrook Labs’ new, ultra-sensitive AptaFluor™ SAH Methyltransferase Assay eliminates cost and sensitivity barriers that are slowing the discovery of methyltransferase inhibitors. Credit: BellBrook Labs

 
 
FURTHER INFORMATION
 
 
 

Related Product News

OmniTier Debuts CompStorTM Novos Platform for De Novo Assembly-based Variant Calling

Product News

CompStor Novos benchmarks show 10x gain in throughput, 70% lower assembly cost/genome; “an important advancement in enabling de novo assembly-based pipelines,” says noted researcher.

READ MORE

Largest Study in Single-Cell Genomics Reveals Heterogeneity Link to Cancer Relapse Using Mission Bio Tapestri® Platform

Product News

The study findings to be presented by MD Anderson Cancer Center at 60th Annual Hematology Meeting in San Diego, CA.

READ MORE

Metrohm USA Contributes to Global Monograph Modernization Initiative

Product News

Metrohm's collaboration with the United States Pharmacopeia will concentrate on the pharmaceutical industry.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Drug Discovery Genomics Research Proteomics & Metabolomics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE